This article is more than 5 years old. Information may no longer be current.

Revenue up 2.9% in first 9 months of fiscal year for Carl Zeiss Meditec

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Carl Zeiss Meditec reported revenue of €649.1 million in the first 9 months of the fiscal year, up 2.9% from €630.8 million in the same period of the previous year, according to a company news release.

For the year, the company is expecting sales to total between €880 million and €910 million, the release said, although a lower gross margin is possible due to competitive pressure in ophthalmology and lower growth rates in microsurgery.

Carl Zeiss Meditec reported a marginal increase in its ophthalmic systems strategic business unit to €266.8 million across the first 9 months of the fiscal year, up from €266.3 million last year. The surgical ophthalmology unit increased 16.2% to €92.7 million, from €79.8 million, while microsurgery increased 1.7%, from €284.7 million to €289.5 million.

Revenues grew at just under 3% in all three business regions — Asia/Pacific, Americas and Europe, Middle East and Africa.